Effectiveness of nurse-led group CBT for hot flushes and night sweats in women with breast cancer: Results of the MENOS4 randomised controlled trial.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
10 2020
Historique:
received: 27 03 2020
revised: 12 05 2020
accepted: 14 05 2020
pubmed: 28 5 2020
medline: 30 12 2020
entrez: 28 5 2020
Statut: ppublish

Résumé

Troublesome hot flushes and night sweats (HFNS) are experienced by many women after treatment for breast cancer, impacting significantly on sleep and quality of life. Cognitive behavioural therapy (CBT) is known to be effective for the alleviation of HFNS. However, it is not known if it can effectively be delivered by specialist nurses. We investigated whether group CBT, delivered by breast care nurses (BCNs), can reduce the impact of HFNS. We recruited women with primary breast cancer following primary treatment with seven or more HFNS/week (including 4/10 or above on the HFNS problem rating scale), from six UK hospitals to an open, randomised, phase 3 effectiveness trial. Participants were randomised to Group CBT or usual care (UC). The primary endpoint was HFNS problem rating at 26 weeks after randomisation. Secondary outcomes included sleep, depression, anxiety and quality of life. Between 2017 and 2018, 130 participants were recruited (CBT:63, control:67). We found a 46% (6.9-3.7) reduction in the mean HFNS problem rating score from randomisation to 26 weeks in the CBT arm and a 15% (6.5-5.5) reduction in the UC arm (adjusted mean difference -1.96, CI -3.68 to -0.23, P = .039). Secondary outcomes, including frequency of HFNS, sleep, anxiety and depression all improved significantly. Our results suggest that specialist nurses can be trained to deliver CBT effectively to alleviate troublesome menopausal hot flushes in women following breast cancer in the NHS setting.

Identifiants

pubmed: 32458473
doi: 10.1002/pon.5432
pmc: PMC7590063
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1514-1523

Subventions

Organisme : Breast Cancer Now
ID : 2015CR_004
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.

Références

J Pain Symptom Manage. 2001 Dec;22(6):979-89
pubmed: 11738160
Cancer Nurs. 2007 Jul-Aug;30(4):E19-26
pubmed: 17666970
Climacteric. 2011 Feb;14(1):171-80
pubmed: 20450413
Br J Psychiatry Suppl. 2000;(39):s28-33
pubmed: 10945075
Drugs Context. 2015 Oct 08;4:212290
pubmed: 26576188
J Consult Clin Psychol. 2005 Oct;73(5):914-23
pubmed: 16287391
Menopause. 2012 Jul;19(7):749-59
pubmed: 22336748
BMC Med. 2010 Oct 20;8:63
pubmed: 20961442
J Clin Oncol. 2012 Nov 20;30(33):4124-33
pubmed: 23045575
Menopause. 2014 Jun;21(6):574-8
pubmed: 24149919
Lancet Oncol. 2012 Mar;13(3):309-18
pubmed: 22340966
Menopause. 2011 Nov;18(11):1178-83
pubmed: 21720279
Menopause. 2008 May-Jun;15(3):469-75
pubmed: 18467951
Eur J Cancer Care (Engl). 2009 Mar;18(2):140-8
pubmed: 19267729
BMC Womens Health. 2018 May 8;18(1):63
pubmed: 29739384
Climacteric. 2006 Feb;9(1):49-58
pubmed: 16428125
Climacteric. 2019 Aug;22(4):419-423
pubmed: 30905177
Psychooncology. 2004 Nov;13(11):769-78
pubmed: 15386641
Maturitas. 2014 May;78(1):56-61
pubmed: 24656221
J Clin Oncol. 2008 Oct 1;26(28):4651-8
pubmed: 18591549
Br J Clin Psychol. 1995 Nov;34(4):589-99
pubmed: 8563666
Menopause. 2015 Nov;22(11):1155-72; quiz 1173-4
pubmed: 26382310
Maturitas. 2008 Jun 20;60(2):158-69
pubmed: 18554828
J Psychosom Obstet Gynaecol. 2017 Dec;38(4):276-283
pubmed: 28762873
Psychooncology. 2020 Oct;29(10):1514-1523
pubmed: 32458473
Behav Cogn Psychother. 2019 Sep;47(5):559-572
pubmed: 30871650
J Clin Oncol. 2019 Apr 1;37(10):809-822
pubmed: 30763176
J Psychosom Res. 2013 Apr;74(4):307-12
pubmed: 23497832
Climacteric. 2019 Dec;22(6):572-578
pubmed: 31433675
J Psychosom Res. 2010 Nov;69(5):491-501
pubmed: 20955869
Gen Hosp Psychiatry. 2013 Jul-Aug;35(4):376-81
pubmed: 23642440

Auteurs

Deborah Fenlon (D)

Department Nursing, College of Human and Health Sciences, Swansea University, Swansea, UK.

Tom Maishman (T)

Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.

Laura Day (L)

Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.

Jacqueline Nuttall (J)

Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.

Carl May (C)

Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.

Mary Ellis (M)

Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.

James Raftery (J)

Primary Care and Population Sciences, University of Southampton, Southampton, UK.

Lesley Turner (L)

Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.

Jo Fields (J)

Ladybird Unit, Poole Hospital NHS Trust, Poole, UK.

Gareth Griffiths (G)

Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.

Myra S Hunter (MS)

Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH